Arcellx (NASDAQ:ACLX – Get Free Report) had its price target boosted by equities researchers at Canaccord Genuity Group from $85.00 to $115.00 in a report released on Thursday, Benzinga reports. The ...
Scotiabank started coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) in a research report sent to investors on Wednesday, MarketBeat.com reports. The firm issued a sector ...